Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Human & Experimental Toxicology|May 1, 1990
Metabolism of aspirin after therapeutic and toxic dosesD K Patel, A Hesse, A Ogunbona, et al.Scandinavian Journal of Gastroenterology|January 1, 1975
Effects of carbenoxolone sodium and of aspirin on gastric mucosal potential difference in normal subjectsP N Bennett, G M Frigo, W M Weerasinghe, et al.British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.Clinical Pharmacology and Therapeutics|September 1, 1995
Studies of the oral bioavailability of alendronateB J Gertz, S D Holland, W F Kline, et al.British Journal of Clinical Pharmacology|June 1, 1990
Use of sodium aurothiomalate during lactationP N Bennett, S J Humphries, J P Osborne, et al.British Journal of Clinical Pharmacology|January 1, 1995
Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activityL J Notarianni, S E Oliver, P Dobrocky, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1982
Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in manP N Bennett, L J Aarons, M R Bending, et al.Scandinavian Journal of Gastroenterology|January 1, 1975
Effect of diazepam on unstimulated and on stimulated gastric secretionP N Bennett, P Davies, G M Frigo, et al.Human Toxicology|July 1, 1985
Digoxin and cimetidine: investigation of the potential for a drug interactionP Crome, B Curl, D Holt, et al.British Journal of Clinical Pharmacology|December 1, 1979
Reduction of circulating 25-hydroxyvitamin D by antipyrineP F Wilmana, M J Brodie, J C Mucklow, et al.Pageof 7